Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Lansoprazole
Matrix: | Human Plasma |
Assay Range: | 2 - 2,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Gastrointestinal |
Classification: | Drug Assays |
Lapatinib
Matrix: | Human Plasma |
Assay Range: | 1 - 100 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Lenvatinib
Matrix: | Human Plasma |
Assay Range: | 1 - 400 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Leptin
Matrix: | Human Serum |
Assay Range: | 15 - 1,000 pg/mL |
Sample Volume: | 0.050 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Leptin
Matrix: | Human Plasma |
Assay Range: | 15 - 1,000 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Lercanidipine
Matrix: | Human Plasma |
Assay Range: | 0.02 - 6 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Letrozole
Matrix: | Human Plasma |
Assay Range: | 0.2 - 100 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Levetiracetam
Matrix: | Human Plasma |
Assay Range: | 0.1 - 40 µg/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anticonvulsant |
Classification: | Drug Assays |
Levocetirizine
Matrix: | Human Plasma |
Assay Range: | 2 - 600 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Antihistamine |
Classification: | Drug Assays |
Levofloxacin
Matrix: | Human Plasma |
Assay Range: | 50 - 10,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Levonorgestrel
Matrix: | Human Plasma |
Assay Range: | 0.2 - 30 ng/ml |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Women's Health |
Classification: | Drug Assays |
Lidocaine
Matrix: | Human Plasma |
Assay Range: | 0.2 - 200 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Lopinavir (LPV)
Ritonavir (RTV)
Ritonavir (RTV)
Matrix: | Human Plasma |
Assay Range: | 100 - 10,000 ng/mL 10 - 6,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Lopinavir (LPV)
Ritonavir (RTV)
Ritonavir (RTV)
Matrix: | Human Plasma |
Assay Range: | 0.1 - 20 µg/mL 0.025 - 5 µg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Lorazepam
Matrix: | Human Plasma |
Assay Range: | 0.2 - 60 ng/mL |
Sample Volume: | 0.4 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Sedative |
Classification: | Drug Assays |
Losartan
Matrix: | Human Plasma |
Assay Range: | 5 - 500 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Losartan
Losartan Carboxy Acid
Losartan Carboxy Acid
Matrix: | Human Plasma |
Assay Range: | 5 - 1,000 ng/mL 5 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Losartan
Losartan Carboxy Acid
Losartan Carboxy Acid
Matrix: | Human Plasma |
Assay Range: | 5 - 1,000 ng/mL 5 - 1,000 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-Taiwan |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Lumefantrine
Matrix: | Human Plasma |
Assay Range: | 0.05 - 20 µg/mL |
Sample Volume: | 0.1mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Anti-parasitic |
Classification: | Drug Assays |
Lurasidone
Matrix: | Human Plasma |
Assay Range: | 0.02 - 50 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antipsychotic |
Classification: | Drug Assays |
Luteinizing Hormone (LH)
Matrix: | Human Serum |
Assay Range: | 0.1 - 200 mIU/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | Immulite |
Site: | QPS-NL |
CLIA: | |
Therapy Area: | |
Classification: | Biochemical Biomarkers |
Magnesium
Matrix: | Human Urine |
Assay Range: | 10.0-100 µg/mL |
Sample Volume: | 10 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
Magnesium
Matrix: | Human Serum |
Assay Range: | 3.00-50.0 µg/mL |
Sample Volume: | 10 µL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | ICP-MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Drug Assays |
MCP-1
Matrix: | Human Serum |
Assay Range: | 20 - 2,000 pg/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
MCP-1
Matrix: | Human Serum |
Assay Range: | 0.61 - 2,500 pg/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | ECL |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT